<html><head><link rel="stylesheet" type="text/css" href="css/style.css"></head><body><div id="main"><h1>Scignal</h1></div> <div class="container"><div class="row"><div class="search"><h2>All Results for :  "cardiac" AND "gene therapy"</a></h2></div><table><tr><td class="head"><h3>BioRxiv</h3></td><td class="head"><h3>PubMed</h3></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: XPO1 gene therapy restores cardiac function in rats with chronic induced myocardial infarction</h4><p><a href="https://www.biorxiv.org/content/10.1101/575340v1">Link</a></p><p><b>Date:</b> 2019-03-12</p><p><b>Authors:</b> María García-Manzanares ... Miguel Rivera</p><p><b>Downloads:</b> 167</p><p><b>Relevance Score:</b> 0.86</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Background: In previous studies, we showed that several nuclear-cytoplasmic transport molecules were closely related to ventricular dysfunction in human heart failure.  Particularly, the transcriptomic signature of XPO1 was highly expressed and inversely related to left ventricular function in heart failure patients of ischemic etiology.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: IL-4 controls activated neutrophil FcγR2b expression and migration into inflamed joints.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31980518">Link</a></p><p><b>Date:</b> 2020-01-25</p><p><b>Authors:</b> Sudeepta Kumar Panda ...  Fredrik Wermeling</p><p><b>Journal:</b> Proc. Natl. Acad. Sci. U.S.A.</p><p><b>IF (7 or above):</b> 9.35</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Neutrophils are the most abundant immune cells found in actively inflamed joints of patients with rheumatoid arthritis (RA), and most animal models for RA depend on neutrophils for the induction of joint inflammation.  Exogenous IL-4 and IL-13 protect mice from antibody-mediated joint inflammation,  ....</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Transient Reprogramming of Neonatal Cardiomyocytes to a Proliferative Dedifferentiated State</h4><p><a href="https://www.biorxiv.org/content/10.1101/801092v1">Link</a></p><p><b>Date:</b> 2019-10-10</p><p><b>Authors:</b> Thomas Kisby ... Kostas Kostarelos</p><p><b>Downloads:</b> 427</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Zebrafish and urodele amphibians are capable of extraordinary myocardial regeneration thanks to the ability of their cardiomyocytes to undergo transient dedifferentiation and proliferation.  Somatic cells can be temporarily reprogrammed to a proliferative, dedifferentiated state through transient expression of Oct3/4, Sox2, Klf4 and c-Myc (OSKM) transcription factors.</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance.</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31355495">Link</a></p><p><b>Date:</b> 2019-07-29</p><p><b>Authors:</b> Smita S Chandran ...  Christopher A Klebanoff</p><p><b>Journal:</b> Immunol. Rev.</p><p><b>IF (7 or above):</b> 10.85</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Adoptive cell transfer (ACT) using chimeric antigen receptor (CAR)-modified T cells can induce durable remissions in patients with refractory B-lymphoid cancers.  By contrast, results applying CAR-modified T cells to solid malignancies have been comparatively modest.</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Viral expression of a SERCA2a-activating PLB mutant improves calcium cycling and synchronicity in dilated cardiomyopathic hiPSC-CMs</h4><p><a href="https://www.biorxiv.org/content/10.1101/699975v3">Link</a></p><p><b>Date:</b> 2019-07-11</p><p><b>Authors:</b> Daniel R Stroik ... David D. Thomas</p><p><b>Downloads:</b> 272</p><p><b>Relevance Score:</b> 0.43</p></div><div class="everything-else-tail"><p><b>Abstract:</b> There is increasing momentum toward the development of gene therapy for heart failure (HF), cardiomyopathy, and other progressive cardiac diseases that correlate with impaired calcium (Ca2+) transport and reduced contractility.  We have used FRET between fluorescently-tagged SERCA2a (the cardiac Ca2+ pump) and PLB (its ventricular peptide regulator) to directly test the effectiveness of loss-of-function/gain-of-binding PLB mutants (PLBM) that were engineered to compete with the binding of inhibitory wild type PLB (PLBWT).</p></div></td></div><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Future prospects for CD8</h4><p><a href="https://ncbi.nlm.nih.gov/pubmed/31593314">Link</a></p><p><b>Date:</b> 2019-10-08</p><p><b>Authors:</b> Léa Flippe ...  Carole Guillonneau</p><p><b>Journal:</b> Immunol. Rev.</p><p><b>IF (7 or above):</b> 10.85</p><p><b>Relevance Score:</b> 0.14</p></div><div class="everything-else-tail"><p><b>Abstract:</b> CD8</p></div></td></div></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Exploring Mechanisms of Inhibition of Amyloid Seeding of Transthyretin</h4><p><a href="https://www.biorxiv.org/content/10.1101/354720v1">Link</a></p><p><b>Date:</b> 2018-06-28</p><p><b>Authors:</b> Lorena Saelices ... David S. Eisenberg</p><p><b>Downloads:</b> 448</p><p><b>Relevance Score:</b> 0.29</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Amyloid deposition of the hormone transporter transthyretin causes familial and sporadic amyloidoses.  The current treatment for familial cases is gene-therapy by liver transplantation.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Impaired Regulation of Redox Transcriptome during the Differentiation of iPSCs into Induced Cardiomyocytes (iCMs)</h4><p><a href="https://www.biorxiv.org/content/10.1101/519793v1">Link</a></p><p><b>Date:</b> 2019-01-14</p><p><b>Authors:</b> Gobinath Shanmugam ... Namakkal S. Rajasekaran</p><p><b>Downloads:</b> 300</p><p><b>Relevance Score:</b> 0.29</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Background: Reprogramming of somatic cells into pluripotent stem cells (iPSC) and subsequent differentiation into iPSC-derived cardiomyocytes (iCM) seems to be a promising strategy for cardiac regenerative therapy.  However, recent failure or poor outcomes in cardiac cell therapy warrants further investigation focusing on the infarction/wound environment (site of healing) to improve the cardiac regenerative medicine.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Rapid pacing by circulating traveling waves improves maturation of hiPSC-derived cardiomyocytes in self-organized tissue ring</h4><p><a href="https://www.biorxiv.org/content/10.1101/717108v1">Link</a></p><p><b>Date:</b> 2019-07-27</p><p><b>Authors:</b> Junjun Li ... Li Liu</p><p><b>Downloads:</b> 231</p><p><b>Relevance Score:</b> 0.29</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Directed differentiation methods allow acquisition of high-purity cardiomyocytes (CMs) differentiated from human induced pluripotent stem cells (hiPSCs); however, their immaturity characteristic limits their application for drug screening and regenerative therapy.  The rapid electrical pacing of cardiomyocytes have been used for efficiently promoting the maturation of cardiomyocytes, here we describe a simple device in modified culture plate on which hiPSC-derived CMs (hiPSC-CMs) can form three-dimensional self-organized tissue rings (SOTRs).</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: The signaling mechanism of Hcy-induced atrial fibrosis mediated by TRPC3</h4><p><a href="https://www.biorxiv.org/content/10.1101/583740v1">Link</a></p><p><b>Date:</b> 2019-03-20</p><p><b>Authors:</b> Lu Han ... Juxiang Li</p><p><b>Downloads:</b> 158</p><p><b>Relevance Score:</b> 0.29</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Background: High plasma levels of homocysteine (Hcy) are regarded as a risk factor for atrial fibrillation (AF), which is closely associated with the pathological consequence of atrial fibrosis and can lead to heart failure with a high mortality rate; Currently, there is no effective therapy for preventing atrial fibrosis, owing to a lack in fundamental understanding of the underlying mechanism.  Here, we show that atrial fibrosis is mediated by the relationship between canonical transient receptor potential 3 (TRPC3) channels and sirtuin type 1 (SIRT1) under the stimulation of Hcy.</p></div></td></div><td></td></tr><tr><div class="row"><div class="col"><td><div class="everything-else-head"><h4 class="title">Title: Animal model and therapeutic prospects for left ventricular hypertrophy and associated renal complication</h4><p><a href="https://www.biorxiv.org/content/10.1101/638353v1">Link</a></p><p><b>Date:</b> 2019-05-14</p><p><b>Authors:</b> Ashfaq Ahmad ... Raheel Qamar</p><p><b>Downloads:</b> 136</p><p><b>Relevance Score:</b> 0.29</p></div><div class="everything-else-tail"><p><b>Abstract:</b> Cardiac and renal dysfunction often co-occur and considerably worsen the prognosis leading to difficulty in therapy in left ventricular hypertrophy (LVH).  The aim of this study was to elucidate changes in expression of human ortholog genes of hypertension, vascular and cardiac remodeling and hypertensive nephropathy phenotypes under normal, disease and gasotransmitter, H2S (hydrogen sulphide) and NO (nitric oxide) and combined (H2S+NO), treatment of rat myocardium and renal tissues.</p></div></td></div><td></td></tr></table></div><hr></div></body></html>